Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
Status:
RECRUITING
Trial end date:
2033-11-01
Target enrollment:
Participant gender:
Summary
The proposed study is designed to treat locally advanced soft tissue sarcoma (STS) subtypes with neoadjuvant talimogene laherparepvec (TVEC) and preoperative external beam radiation therapy (EBRT).